The protooncogene Vav functions as a GDP/GTP exchange factor (GEF) for Rho-
like small GTPases involved in cytoskeletal reorganization and cytokine pro
duction in T cells. Gene-targeted mice lacking Vav have a severe defect in
positive and negative selection of T cell antigen receptor transgenic thymo
cytes in vivo, and vav(-/-) thymocytes are completely resistant to peptide-
specific and anti-CD3/anti-CD28-mediated apoptosis. Vav acts upstream of mi
te chondrial pore opening and caspase activation. Biochemically, Vav regula
tes peptide-specific Ca2+ mobilization and actin polymerization. Peptide-sp
ecific cell death was blocked both by cytochalasin D inhibition of actin po
lymerization and by inhibition of protein kinase C (PKC). Activation of PKC
with phorbol ester restored peptide-specific apoptosis in vav(-/-) thymocy
tes. Vav was found to bind constitutively to PKC-theta in thymocytes. Our r
esults indicate that peptide-triggered thymocyte apoptosis is mediated via
Vav activation, changes in the actin cytoskeleton, and subsequent activatio
n of a PKC isoform.